Shenzhen Hepalink Pharmaceutical Group Co Ltd

09989

Company Profile

  • Business description

    Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business, and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from USA and Europe.

  • Contact

    No. 21 Langshan Road
    Songping Mountain
    Guangdong Province, Nanshan District
    Shenzhen518057
    CHN

    T: +86 75526980200

    https://www.hepalink.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,080

Stocks News & Analysis

stocks

2 undervalued ASX shares report

These two ASX shares are trading at a discount to our fair value. 
stocks

Turmoil at WiseTech

Board members step down over differences on the role of former CEO Richard White.
video

What does the RBA rate cut mean for investors?

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,494.5065.60-0.77%
CAC 408,090.9963.52-0.78%
DAX 4022,425.93138.370.62%
Dow JONES (US)43,461.2133.190.08%
FTSE 1008,658.980.39-0.00%
HKSE22,998.69342.92-1.47%
NASDAQ19,286.93237.08-1.21%
Nikkei 22538,345.99430.95-1.11%
NZX 50 Index12,355.74175.98-1.40%
S&P 5005,983.2529.88-0.50%
S&P/ASX 2008,247.0061.20-0.74%
SSE Composite Index3,359.2713.76-0.41%

Market Movers